Hazelten: There are several concerns. Number one concerned is, will you mutate sars covid is something worse than it is? That is a real danger. We don't want somebody taking a small dose, by accident of the drug and mutating it. So it doesn't die, but it just gets worseo anyido, i think the fda has got to be very, very cautious in their approval of this drug.
Dr. William Haseltine, Chairman and President of Access Health International, on virus news and the development of the drug Molnupiravir. Bloomberg News Editor-at-Large Erik Schatzker on Hertz orders 100,000 Teslas in car-rental industry shake-up. Bloomberg News Deal Reporter Ed Hammond on M&A Heads to Record $5 Trillion Year Despite, Well, Everything. Bloomberg New Economy Editorial Director Andy Browne on The Flaw at the Center of China’s Bubble. Bloomberg News Social Media Reporter Naomi Nix and Bloomberg News Tech Reporter Kurt Wagner on Facebook’s eventful day. And we Drive to the Close with Nadia Lovell, Senior Equity Strategist at UBS Global Wealth Management
Hosted by Carol Massar and Tim Stenovec. Producer: Paul Brennan
See omnystudio.com/listener for privacy information.